Survival differences according to baseline characteristics of patient with advanced heart failure treated with levosimendan
Our preliminary data suggest that the only characteristic that could predict worse survival in patients with advanced heart failure treated with levosimendan is N-terminal pro-brain natriuretic peptide levels greater than 6000 pg/ml. Future research is needed to confirm our findings.
Authors
- Alejandro Mariño (ORCID: https://orcid.org/0000-0002-6329-6692)
- Óscar Múñoz (ORCID: https://orcid.org/0000-0001-5401-0018)
- Ángel Alberto García Peña (ORCID: https://orcid.org/0000-0002-3606-2102)
- Daniela Saa-González
Institutions
- Pontificia Universidad Javeriana (CO)
- Hospital Universitario San Ignacio (CO)
Publication Details
- Journal
- SAGE Open Medicine
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1177/20503121251357357
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39